SEB Asset Management AB »

Oruka Therapeutics shares owned by SEB Asset Management AB

Quarter-by-quarter ownership of Oruka Therapeutics (ORKA) shares owned by SEB Asset Management AB from 13F filings

Historical chart of SEB Asset Management AB investment in Oruka Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Oruka Therapeutics held by SEB Asset Management AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oruka Therapeutics by SEB Asset Management AB

Quarter filed Position value Share count Share price at filing
2026-06-30 $19M 197k 95.17

More positions owned by SEB Asset Management AB

NVIDIA Corporation (NVDA)
Apple (AAPL)
Astrazeneca Ord (AZN)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Micron Technology (MU)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Advanced Micro Devices (AMD)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
Applied Materials (AMAT)

View all positions for SEB Asset Management AB

Top funds holding Oruka Therapeutics

FMR
VR Adviser
Fairmount Funds Management
BlackRock
Viking Global Investors
Vanguard Capital Management
Paradigm Biocapital Advisors
Rtw Investments
Deep Track Capital
State Street Corporation
Remedium Capital Partners
Perceptive Advisors
Polar Capital Holdings
Citadel Advisors
Franklin Resources

View all funds holding Oruka Therapeutics